Literature DB >> 12364375

Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Maria Grazia Revello1, Giuseppe Gerna.   

Abstract

Human cytomegalovirus (HCMV) is the leading cause of congenital viral infection and mental retardation. HCMV infection, while causing asymptomatic infections in most immunocompetent subjects, can be transmitted during pregnancy from the mother with primary (and also recurrent) infection to the fetus. Hence, careful diagnosis of primary infection is required in the pregnant woman based on the most sensitive serologic assays (immunoglobulin M [IgM] and IgG avidity assays) and conventional virologic and molecular procedures for virus detection in blood. Maternal prognostic markers of fetal infection are still under investigation. If primary infection is diagnosed in a timely manner, prenatal diagnosis can be offered, including the search for virus and virus components in fetal blood and amniotic fluid, with fetal prognostic markers of HCMV disease still to be defined. However, the final step for definite diagnosis of congenital HCMV infection is detection of virus in the blood or urine in the first 1 to 2 weeks of life. To date, treatment of congenital infection with antiviral drugs is only palliative both prior to and after birth, whereas the only efficacious preventive measure seems to be the development of a safe and immunogenic vaccine, including recombinant, subunit, DNA, and peptide-based vaccines now under investigation. The following controversial issues are discussed in the light of the most recent advances in the field: the actual perception of the problem; universal serologic screening before pregnancy; the impact of correct counseling on decision making by the couple involved; the role of prenatal diagnosis in ascertaining transmission of virus to the fetus; the impact of preconceptional and periconceptional infections on the prevalence of congenital infection; and the prevalence of congenitally infected babies born to mothers who were immune prior to pregnancy compared to the number born to mothers undergoing primary infection during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364375      PMCID: PMC126858          DOI: 10.1128/CMR.15.4.680-715.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  286 in total

Review 1.  Cytomegalovirus vaccine.

Authors:  S A Plotkin
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

Review 2.  Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors:  T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

3.  Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease.

Authors:  G J Demmler
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

4.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  PCR detection of cytomegalovirus DNA in serum as a diagnostic test for congenital cytomegalovirus infection.

Authors:  C T Nelson; A S Istas; M K Wilkerson; G J Demmler
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

Authors:  S P Adler; S A Plotkin; E Gonczol; M Cadoz; C Meric; J B Wang; P Dellamonica; A M Best; J Zahradnik; S Pincus; K Berencsi; W I Cox; Z Gyulai
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

7.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

8.  Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.

Authors:  M G Revello; E Percivalle; M Zavattoni; M Parea; P Grossi; G Gerna
Journal:  J Med Virol       Date:  1989-10       Impact factor: 2.327

9.  Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.

Authors:  G Gerna; D Zipeto; M Parea; M G Revello; E Silini; E Percivalle; M Zavattoni; P Grossi; G Milanesi
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

10.  Is antenatal screening for rubella and cytomegalovirus justified?

Authors:  B D Schoub; S Johnson; J M McAnerney; N K Blackburn; F Guidozzi; D Ballot; A Rothberg
Journal:  S Afr Med J       Date:  1993-02
View more
  141 in total

1.  Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.

Authors:  Suresh B Boppana; Shannon A Ross; Masako Shimamura; April L Palmer; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; Zdenek Novak; Nazma Chowdhury; William J Britt; Karen B Fowler
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

2.  Early identification of human cytomegalovirus strains by the shell vial assay is prevented by a novel amino acid substitution in UL123 IE1 gene product.

Authors:  G Gerna; F Baldanti; E Percivalle; M Zavattoni; G Campanini; M G Revello
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 3.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

4.  Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.

Authors:  Qiyi Tang; Nadia R Roan; Yasuhiro Yamamura
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection.

Authors:  Christelle Vauloup-Fellous; Aurélie Ducroux; Vincent Couloigner; Sandrine Marlin; Olivier Picone; Julie Galimand; Natalie Loundon; Françoise Denoyelle; Liliane Grangeot-Keros; Marianne Leruez-Ville
Journal:  J Clin Microbiol       Date:  2007-09-26       Impact factor: 5.948

6.  Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine.

Authors:  Naoki Nozawa; Shin Koyano; Yumiko Yamamoto; Yuhki Inami; Ichiro Kurane; Naoki Inoue
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

7.  Gastrointestinal Infections Caused by Cytomegalovirus.

Authors:  David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

8.  Excluding Anti-cytomegalovirus Immunoglobulin M-Positive Cord Blood Units Has a Minimal Impact on the Korean Public Cord Blood Bank Inventory.

Authors:  Sue Shin; Eun Youn Roh; Sohee Oh; Eun Young Song; Eui Chong Kim; Jong Hyun Yoon
Journal:  Cell Transplant       Date:  2016-08-12       Impact factor: 4.064

9.  Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin g avidity to human cytomegalovirus.

Authors:  Maria Grazia Revello; Giovanna Gorini; Giuseppe Gerna
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.

Authors:  A Reitter; H Buxmann; A E Haberl; R Schlösser; M Kreibich; O T Keppler; A Berger
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.